Open $119.08
Day Range 119.00 - 125.24
52 Week Range 103.31 - 306.72
Market Cap $5.07B
Shares Outstanding 42.55M
Public Float 37.48M
Beta 0.70
Rev. per Employee $1.213M
P/E Ratio 5.73
EPS $21.74
Yield N/A
Dividend N/A
Ex-Dividend Date N/A
Short Interest 5.02M 06/15/21
% of Float Shorted 13.39%
Average Volume 811.72K

5 Day	11.97%
1 Month	6.01%
3 Month	1.64%
YTD	-30.30%
1 Year	-40.50%

Sell
Under
Hold
Over
Buy

Number of Ratings 6 Full Ratings

MarketWatch
Dow Jones

Quidel price target cut to $141 from $160 t Raymond James, stock rated outperform

Jun. 28, 2021 at 9:40 a.m. ET by Tonya Garcia

Quidel: Sofia Q Rapid Antigen Test Device Gets Amended EUA From FDA

Jun. 11, 2021 at 4:39 p.m. ET

Quidel Says SARS Antigen FIA Test to Detect Coronavirus Approved by Health Canada

May. 24, 2021 at 4:27 p.m. ET

Quidel upgraded to outperform from market perform at Raymond James

Jan. 22, 2021 at 7:37 a.m. ET by Tomi Kilgore

New rapid, daily coronavirus testing could save Pac-12 football, basketball seasons

Sep. 3, 2020 at 9:49 p.m. ET by Associated Press

Quidel stock price target raised to $158 from $120 at J.P. Morgan

May. 12, 2020 at 7:54 a.m. ET by Tomi Kilgore

Quidel downgraded to underweight from neutral at J.P. Morgan

May. 12, 2020 at 7:53 a.m. ET by Tomi Kilgore

Premium

Bear-market rally accelerates, S&P 500 reclaims latest key technical level

Mar. 26, 2020 at 12:00 p.m. ET by Michael Ashbaugh

Opinion

Three stocks that are ‘part of the solution’ to the coronavirus crisis

Mar. 24, 2020 at 6:51 a.m. ET by Philip van Doorn

How to profit from the ‘best of both worlds’ in stock investing

Sep. 23, 2019 at 10:20 a.m. ET by Philip van Doorn

Quidel Corp.maintained as strong buy at Raymond James

May. 30, 2019 at 8:09 a.m. ET by Ciara Linnane

Quidel Corp. price target cut to $70 from $80 at Raymond James

Dec. 11, 2018 at 8:57 a.m. ET by Tonya Garcia

How to find ‘coming of age’ companies whose stocks could rise 10-fold

Apr. 24, 2018 at 3:14 a.m. ET by Philip van Doorn

Quidel upgraded to strong buy from outperform at Raymond James

Mar. 8, 2018 at 8:42 a.m. ET by Tomi Kilgore

Expect better, more reliable flu tests

Feb. 24, 2018 at 8:12 a.m. ET by Peter Loftus

Barron's

Charting the Market

Jul. 22, 2017 at 12:13 a.m. ET by Barron's

Quidel upgraded to outperform from market perform at Raymond James

Jun. 13, 2016 at 8:13 a.m. ET by Tomi Kilgore

Friday’s biggest gaining and declining stocks

Jan. 4, 2013 at 9:45 a.m. ET by Greg Morcroft

Stocks to watch Monday: Elan, Barnes & Noble

Aug. 13, 2012 at 6:46 a.m. ET by MarketWatch

Premium

Major U.S. benchmarks top the 50-day

Aug. 18, 2008 at 10:20 a.m. ET by Michael Ashbaugh

No Headlines Available

Other News
Press Releases

Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know

Jun. 24, 2021 at 5:50 p.m. ET on Zacks.com

3 Stocks Wall Street Thinks Will Skyrocket 50% or More

Jun. 19, 2021 at 6:02 a.m. ET on Motley Fool

Quidel (QDEL) Gains As Market Dips: What You Should Know

Jun. 18, 2021 at 5:45 p.m. ET on Zacks.com

Zacks Value Investor Highlights: Hibbett Sports, CoDiagnostics, Quidel Corp, DHT Holdings and Rocket Companies

Jun. 18, 2021 at 6:35 a.m. ET on Zacks.com

Screening for Ben Graham Value Stocks

Jun. 17, 2021 at 12:53 p.m. ET on Zacks.com

Quidel (QDEL) Gains As Market Dips: What You Should Know

Jun. 16, 2021 at 5:50 p.m. ET on Zacks.com

Monday’s Pre-Market: Here’s What You Need to Know Before the Market Opens

Jun. 14, 2021 at 8:42 a.m. ET on TipRanks.com

Quidel Bags Amended EUA from FDA for New Sofia Q Device

Jun. 14, 2021 at 6:59 a.m. ET on TipRanks.com

11 Stocks That Could Profit From a Predicted Nasty Cold-and-Flu Season

Jun. 13, 2021 at 7:01 a.m. ET on Motley Fool

Lower Testing Shouldn’t Lower Quidel

Jun. 13, 2021 at 5:18 a.m. ET on TipRanks.com

What Should Investors Make of Abbott's Reduced Full-Year Guidance?

Jun. 12, 2021 at 7:01 a.m. ET on Motley Fool

NVIDIA, Quidel, Volkswagen, Daimler and BMW highlighted as Zacks Bull and Bear of the Day

Jun. 11, 2021 at 8:40 a.m. ET on Zacks.com

Bear of the Day: Quidel (QDEL)

Jun. 11, 2021 at 6:20 a.m. ET on Zacks.com

Quidel (QDEL) Gains As Market Dips: What You Should Know

Jun. 9, 2021 at 5:45 p.m. ET on Zacks.com

The Bottom Is in for These 3 Stocks? Analysts Say ‘Buy’

Jun. 7, 2021 at 11:11 a.m. ET on TipRanks.com

How Long Will Fulgent Genetics Benefit From the Pandemic?

May. 29, 2021 at 12:45 p.m. ET on Motley Fool

3 High-Growth Stocks That Could Soar

May. 29, 2021 at 6:40 a.m. ET on Motley Fool

7 Former Pandemic Stocks to Buy That Are No Longer Running Hot

May. 26, 2021 at 10:07 a.m. ET on InvestorPlace.com

Why Quidel Stock Jumped Today

May. 7, 2021 at 1:58 p.m. ET on Motley Fool

Quidel Corp (QDEL) Q1 2021 Earnings Call Transcript

May. 7, 2021 at 6:31 a.m. ET on Motley Fool

No Headlines Available

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Name	Chg %	Market Cap
Thermo Fisher Scientific Inc.	2.07%	$193.71B
Bio-Rad Laboratories Inc. Cl B	0.00%	$17.36B
Meridian Bioscience Inc.	2.07%	$909.06M
PerkinElmer Inc.	0.73%	$17.09B
Becton Dickinson & Co.	0.80%	$70.15B
OraSure Technologies Inc.	4.79%	$687.94M
Danaher Corp.	1.17%	$190.13B

Competitor Data Provided By